Very Late Recurrence in Breast Cancer: Is Breast Cancer a Chronic Disease?

Although breast cancer treatments have made great strides in recent decades, there are still many recurrences. Late recurrence is one of the characteristics of breast cancer. Here, we present four cases of recurrence more than 10 years after the initial diagnosis. The time from diagnosis to recurren...

Full description

Saved in:
Bibliographic Details
Published inCurēus (Palo Alto, CA) Vol. 14; no. 3; p. e22804
Main Authors Kamata, Arimichi, Hino, Koji, Kamiyama, Koki, Takasaka, Yoshihiro
Format Journal Article
LanguageEnglish
Published United States Cureus Inc 03.03.2022
Cureus
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Although breast cancer treatments have made great strides in recent decades, there are still many recurrences. Late recurrence is one of the characteristics of breast cancer. Here, we present four cases of recurrence more than 10 years after the initial diagnosis. The time from diagnosis to recurrence was 13 to 20 years in our four cases, which were all estrogen receptor (ER)-positive, and one was also human epidermal growth factor receptor 2-positive. Long-term hormone therapy for 10 years is necessary to prevent late recurrence of breast cancer, but we need to know that late recurrence remains common. Risk factors for late recurrence include ER positivity, progesterone receptor positivity, and low Ki67. The most common sites of recurrence are the lungs/pleura and bones, which was also the case in our experience. It is no exaggeration to say that breast cancer is a chronic disease similar to hypertension and diabetes. This is because breast cancer is not completely cured by surgery alone and lasts for a long time, with patients requiring long-term hormone therapy. Moreover, it can recur even after 10 years or more.
AbstractList Although breast cancer treatments have made great strides in recent decades, there are still many recurrences. Late recurrence is one of the characteristics of breast cancer. Here, we present four cases of recurrence more than 10 years after the initial diagnosis. The time from diagnosis to recurrence was 13 to 20 years in our four cases, which were all estrogen receptor (ER)-positive, and one was also human epidermal growth factor receptor 2-positive. Long-term hormone therapy for 10 years is necessary to prevent late recurrence of breast cancer, but we need to know that late recurrence remains common. Risk factors for late recurrence include ER positivity, progesterone receptor positivity, and low Ki67. The most common sites of recurrence are the lungs/pleura and bones, which was also the case in our experience. It is no exaggeration to say that breast cancer is a chronic disease similar to hypertension and diabetes. This is because breast cancer is not completely cured by surgery alone and lasts for a long time, with patients requiring long-term hormone therapy. Moreover, it can recur even after 10 years or more.
Author Kamiyama, Koki
Takasaka, Yoshihiro
Kamata, Arimichi
Hino, Koji
AuthorAffiliation 1 Surgery, Tomei Atsugi Hospital, Atsugi, JPN
AuthorAffiliation_xml – name: 1 Surgery, Tomei Atsugi Hospital, Atsugi, JPN
Author_xml – sequence: 1
  givenname: Arimichi
  surname: Kamata
  fullname: Kamata, Arimichi
  organization: Surgery, Tomei Atsugi Hospital, Atsugi, JPN
– sequence: 2
  givenname: Koji
  surname: Hino
  fullname: Hino, Koji
  organization: Surgery, Tomei Atsugi Hospital, Atsugi, JPN
– sequence: 3
  givenname: Koki
  surname: Kamiyama
  fullname: Kamiyama, Koki
  organization: Surgery, Tomei Atsugi Hospital, Atsugi, JPN
– sequence: 4
  givenname: Yoshihiro
  surname: Takasaka
  fullname: Takasaka, Yoshihiro
  organization: Surgery, Tomei Atsugi Hospital, Atsugi, JPN
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35382184$$D View this record in MEDLINE/PubMed
BookMark eNpVkN1LwzAUxYNMnM69-SwBX-3MR5M2PihavyYDQdTXkGa3rmNrZ9IK---Nbo7t6ebmHH73cI5Qp6orQOiEkkGSCHVhWwetHzCWkngPHTIq0yiladzZendR3_spIYSShJGEHKAuFzxlQTpEzx_glnhkGsCvEGgOKgu4rPCtA-MbnJmwu0s89Ls_2OBs4uqqtPiu9EGA62O0X5iZh_569tD7w_1b9hSNXh6H2c0ospyoJgoZREzyOFeFTbkCkahYwRgSYdOiSFXCOQWrZC6JsWMBsWSMWVoYMFSCUbyHrlbcRZvPYWyhapyZ6YUr58YtdW1KvatU5UR_1t86sGUseACcrQGu_mrBN3pat64KmTWTIpGcc0mD63zlsq723kGxuUCJ_i1fr8rXf-UH--l2qo35v2r-A4mngiQ
CitedBy_id crossref_primary_10_1007_s13691_024_00698_y
Cites_doi 10.1016/S0140-6736(12)61963-1
10.1200/JCO.2015.62.3504
10.1056/NEJMoa1113216
10.1002/cncr.27472
10.1200/JCO.2007.11.3787
10.1002/ijc.31914
10.4030/jjcs.39.870
10.2147/BCTT.S26431
10.1016/S0140-6736(11)60993-8
10.1002/14651858.CD006243.pub2
10.1001/jama.1994.03510440047031
10.1159/000502636
10.1001/jama.271.20.1593
10.1056/NEJMoa1703643
10.1159/000353099
ContentType Journal Article
Copyright Copyright © 2022, Kamata et al.
Copyright © 2022, Kamata et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2022, Kamata et al. 2022 Kamata et al.
Copyright_xml – notice: Copyright © 2022, Kamata et al.
– notice: Copyright © 2022, Kamata et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2022, Kamata et al. 2022 Kamata et al.
DBID NPM
AAYXX
CITATION
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOI 10.7759/cureus.22804
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList Publicly Available Content Database

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2168-8184
ExternalDocumentID 10_7759_cureus_22804
35382184
Genre Case Reports
GroupedDBID 3V.
53G
5VS
7X7
8FI
8FJ
ABUWG
ADBBV
ADRAZ
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
FYUFA
GROUPED_DOAJ
HMCUK
HYE
KQ8
M48
NPM
OK1
PGMZT
PIMPY
PQQKQ
PROAC
RPM
UKHRP
AAYXX
CITATION
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
5PM
ID FETCH-LOGICAL-c309t-720540b4b9fc839e57949ede75c8ff897331ec96b60acd5e46222c1faea16ea93
IEDL.DBID RPM
ISSN 2168-8184
IngestDate Tue Sep 17 21:13:33 EDT 2024
Thu Oct 10 18:02:07 EDT 2024
Fri Aug 23 01:37:35 EDT 2024
Sat Sep 28 08:21:15 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords er-positive
relapse-free interval
breast cancer
chronic disease
late recurrence
Language English
License Copyright © 2022, Kamata et al.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c309t-720540b4b9fc839e57949ede75c8ff897331ec96b60acd5e46222c1faea16ea93
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976453/
PMID 35382184
PQID 2657633361
PQPubID 2045583
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8976453
proquest_journals_2657633361
crossref_primary_10_7759_cureus_22804
pubmed_primary_35382184
PublicationCentury 2000
PublicationDate 2022-03-03
PublicationDateYYYYMMDD 2022-03-03
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-03
  day: 03
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Palo Alto
– name: Palo Alto (CA)
PublicationTitle Curēus (Palo Alto, CA)
PublicationTitleAlternate Cureus
PublicationYear 2022
Publisher Cureus Inc
Cureus
Publisher_xml – name: Cureus Inc
– name: Cureus
References ref12
Banys M (ref7) 2012; 4
Takebayashi K (ref8) 2014; 39
Elfgen C (ref16) 2020; 15
(ref14) 1994; 271
Davies C (ref1) 2011; 378
von Minckwitz G (ref4) 2017; 377
Davies C (ref9) 2013; 381
Gerber LH (ref13) 2012; 118
van Maaren MC (ref5) 2019; 144
Nishimura R (ref10) 2013; 85
Baselga J (ref6) 2012; 366
Rosselli Del Turco M (ref15) 1994; 271
De Laurentiis M (ref2) 2008; 26
Colleoni M (ref11) 2016; 34
Moja L (ref3) 2012
References_xml – volume: 381
  year: 2013
  ident: ref9
  article-title: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)61963-1
  contributor:
    fullname: Davies C
– volume: 34
  year: 2016
  ident: ref11
  article-title: Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group Trials I to V
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2015.62.3504
  contributor:
    fullname: Colleoni M
– volume: 366
  year: 2012
  ident: ref6
  article-title: Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1113216
  contributor:
    fullname: Baselga J
– volume: 118
  year: 2012
  ident: ref13
  article-title: Integrating a prospective surveillance model for rehabilitation into breast cancer survivorship care
  publication-title: Cancer
  doi: 10.1002/cncr.27472
  contributor:
    fullname: Gerber LH
– volume: 26
  year: 2008
  ident: ref2
  article-title: Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.11.3787
  contributor:
    fullname: De Laurentiis M
– volume: 144
  year: 2019
  ident: ref5
  article-title: Ten-year recurrence rates for breast cancer subtypes in the Netherlands: a large population-based study
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31914
  contributor:
    fullname: van Maaren MC
– volume: 39
  year: 2014
  ident: ref8
  article-title: Breast cancer recurrence as peritoneal metastasis 42 years after total mastectomy
  publication-title: J Japanese Soc Surg
  doi: 10.4030/jjcs.39.870
  contributor:
    fullname: Takebayashi K
– volume: 4
  year: 2012
  ident: ref7
  article-title: Dormancy in breast cancer
  publication-title: Breast Cancer (Dove Med Press)
  doi: 10.2147/BCTT.S26431
  contributor:
    fullname: Banys M
– volume: 378
  year: 2011
  ident: ref1
  article-title: Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)60993-8
  contributor:
    fullname: Davies C
– year: 2012
  ident: ref3
  article-title: Trastuzumab containing regimens for early breast cancer
  publication-title: Cochrane Database Syst Rev
  doi: 10.1002/14651858.CD006243.pub2
  contributor:
    fullname: Moja L
– volume: 271
  year: 1994
  ident: ref14
  article-title: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators
  publication-title: JAMA
  doi: 10.1001/jama.1994.03510440047031
– volume: 15
  year: 2020
  ident: ref16
  article-title: Metastatic breast cancer as a chronic disease: evidence-based data on a theoretical concept
  publication-title: Breast Care (Basel)
  doi: 10.1159/000502636
  contributor:
    fullname: Elfgen C
– volume: 271
  year: 1994
  ident: ref15
  article-title: Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up
  publication-title: JAMA
  doi: 10.1001/jama.271.20.1593
  contributor:
    fullname: Rosselli Del Turco M
– volume: 377
  year: 2017
  ident: ref4
  article-title: Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1703643
  contributor:
    fullname: von Minckwitz G
– volume: 85
  year: 2013
  ident: ref10
  article-title: Evaluation of factors related to late recurrence--later than 10 years after the initial treatment--in primary breast cancer
  publication-title: Oncology
  doi: 10.1159/000353099
  contributor:
    fullname: Nishimura R
– ident: ref12
SSID ssj0001072070
Score 2.239197
Snippet Although breast cancer treatments have made great strides in recent decades, there are still many recurrences. Late recurrence is one of the characteristics of...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage e22804
SubjectTerms Breast cancer
Cancer therapies
Case reports
Chemotherapy
Dissection
Drug therapy
Endocrine therapy
Epidermal growth factor
Estrogens
General Surgery
Hospitals
Internal Medicine
Liver
Lumpectomy
Lymphatic system
Mastectomy
Medical imaging
Metastasis
Oncology
Patients
Pleural effusion
Radiation therapy
Surgery
Tomography
Tumors
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV05T8MwFLagSIgFcRMoyAOMoUl8xSwVV1UqyoAo6hY5jiO6pCVNB_49z0laCEiscWTLn4_3-Z0IXUgae1Ir5vJYSJemRrmhBCIXakqZUCFVygYnD595f0QHYzauFW7z2q1yeSeWF3Uy1VZH3gk4MGNCCPe7sw_XVo2y1tW6hMY62vADj1uXLjEW3zoWTwSwpSt_dyGY7OhFbhbzK5sDhjYl0R96-dtL8ofY6e2g7Zov4ptqgXfRmsn20Oawtojvo8GbyT_xEzBG_GJV52XwHp5k-NZ6mxf4zq5qfo0f580vWOE6Ly6-r2w03QM06j283vXduj6Cq4knCxcmB3wrprFMNfAcw-BsSZMYwXSYpqG05RiNljzmntIJM5QDGdB-qozyuVGSHKJWNs3MMcIBjSkIbl_FQKAUXIJEh4kHPZoECEoqHHS5xCqaVWkwIng-WEyjCtOoxNRB7SWQUX0YoGW1dA46qjBddUJgLPvKdJBooL36waa_brZkk_cyDTZMkFNGTv4f8hRtBTZiwbqNkTZqFfnCnAGPKOLzcrN8AUIsySM
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH9BTIwX47dTND3ocTjWrlu9EEUJEvFgxHBbutJFEjN1jET-e1_3QUSM121t099r936vfR8A54JFjlDSs3nkC5vFWtqBQCIXKMY8XwZMShOcPHjkvSHrj7xRDapqoyWA0z9NO1NPapi-Nb8-523c8Mhfm77viUs1S_Vs2jSJXdgarLsMbXTjxFcS_fy0xfFdXNyF5_tKo2WdtEI0f_tL_lBA3W3YKpkjuS5EvQM1nezCxqC8G9-D_otO5-QBuSN5MofoeRgfmSTkxvidZ6Rj5Jtekfvp8hMiSZkhl9wWtzXtfRh27547PbuslGAr6ojMxskh84pYJGKFjEd7uMuEHmvfU0EcB8IUZtRK8Ig7Uo09zTjSAtWKpZYtrqWgB1BP3hN9BMRlEUMV3pIRUimJv0OqgrGDPeoxUpXYt-Ciwir8KBJihGhIGEzDAtMwx9SCRgVkWEk1dDmaN5RS3rLgsMB00QnFsYy9aYG_hPbiA5MIe_lNMnnNE2LjBDnz6PH_Q57ApmtiF4wDGW1APUtn-hQZRRad5YvlGxwhzFI
  priority: 102
  providerName: Scholars Portal
Title Very Late Recurrence in Breast Cancer: Is Breast Cancer a Chronic Disease?
URI https://www.ncbi.nlm.nih.gov/pubmed/35382184
https://www.proquest.com/docview/2657633361
https://pubmed.ncbi.nlm.nih.gov/PMC8976453
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT8IwFH5RTIwX429RJD3ocbDRdl29GEGNGiHEiOG2tKWLJDINwsH_3tf9IKA3j1u3Zvv6mve99nuvAOeSaV8axb1QC-mxxCovkkjkIsMYFypiSrnk5G4vvB-wxyEfrgEvc2Ey0b7R40b6Pmmk47dMW_k5Mc1SJ9bsdzsR-lDGaXMd1tFAl0L0bGHFFy2041zkLgSXTTOf2vlXwxV-ccfwUJzjLrBZ9UR_6OVvleSS27nbge2CL5Lr_Lt2Yc2me7DZLXbE9-Hx1U6_yRMyRvLsls6z5D0yTknbqc1npONGdXpJHr5W7xBFirq45Cbfo7k6gMHd7Uvn3ivOR_AM9eXMw_9EvqWZlolBnmM5zi1pR1ZwEyUJgkRpYI0MdegrM-KWhUgGTJAoq4LQKkkPoZJ-pPYYSItpho47UBoJlEKAqIlGPvZoR0hQElGFixKr-DMvgxFj-ODgjXN44wzeKtRKIONiMmBLiEENpTQMqnCUY7ropByMKogVtBcPuPLXqy1oFVkZ7MIKTv795ilstVwyg1OU0RpUZtO5PUOKMdN1NKyhqMNG-7bXf8arLovqmZn9AC9J1Yk
link.rule.ids 230,315,730,783,787,888,2228,12068,21400,24330,27936,27937,31731,33756,43322,43817,53804,53806,74073,74630
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3LT8IwGP-imKgX41sUtQc9Tgbt2tULUZQAAgcDhtvSdV3kMpDHwf_er9tA0cTrurTpr4_v1-8JcCNZ6EqtPIeHQjosNsrxJRI5XzPmCeUzpWxwcrfHmwPWHnrDXOE2y90ql3dielFHY2115OUqR2ZMKeWV2uTDsVWjrHU1L6GxCVs2D5etYCCG4lvH4ooqbunM310IT5b1YmoWszubA4atS6I_9PK3l-QPsdPYh72cL5KHbIEPYMMkh7DdzS3iR9B-M9NP0kHGSF6t6jwN3iOjhDxab_M5qdtVnd6T1mz9C1Ekz4tLnjIbTe0YBo3nfr3p5PURHE1dOXdwcsi3QhbKWCPPMR6eLWkiIzztx7EvbTlGoyUPuat05BnGkQzoSqyMqnCjJD2BQjJOzBmQKgsZCu6KCpFAKbwEqfYjF3s0ERKUWBThdolVMMnSYAT4fLCYBhmmQYppEUpLIIP8MGDLaumKcJphuuqE4lj2lVkEsYb26geb_nq9JRm9p2mwcYKcefT8_yGvYafZ73aCTqv3cgG7VRu9YF3IaAkK8-nCXCKnmIdX6cb5AsuyzAo
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTwIxEJ4oJsaL8S0-e9DjykK77daLEYGAAjFEDLdNt9uNXBblcfDfO2ULiiZet5s2_dpOv7bfzABcSRb7UqvA47GQHkuN8kKJRC7UjAVChUwp65zc6fJmnz0OgoHTP02crHJhE-eGOhlpe0deqnBkxpRSXi6lThbxXGvcvX94NoOUfWl16TTWYUMwTv0CbFTr3efe942LLyo4wXP1uxCBLOnZ2MwmNzYiDFvdl_6Qzd-ayR-bUGMHth17JPf5cO_Cmsn2YLPj3sf34fHVjD9JG_kj6dmL9LkrHxlmpGq151PyYMd4fEtak9UvRBEXJZfU8hebuwPoN-ovD03PZUvwNPXl1MPOIfuKWSxTjazHBLjSpEmMCHSYpqG0yRmNljzmvtJJYBhHaqDLqTKqzI2S9BAK2Sgzx0AqLGa4jZdVjHRKoUmkOkx8rNEkSFdSUYTrBVbRex4UI8LDhMU0yjGN5pgW4WwBZOSWBpYsB7IIRzmmy0ootmXPnEUQK2gvf7DBsFdLsuHbPCg2dpCzgJ783-QlbOKsidqt7tMpbFWsK4PVk9EzKEzHM3OOBGMaX7iZ8wWlcdGn
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Very+Late+Recurrence+in+Breast+Cancer%3A+Is+Breast+Cancer+a+Chronic+Disease%3F&rft.jtitle=Cur%C4%93us+%28Palo+Alto%2C+CA%29&rft.au=Kamata+Arimichi&rft.au=Hino+Koji&rft.au=Kamiyama+Koki&rft.au=Takasaka+Yoshihiro&rft.date=2022-03-03&rft.pub=Cureus+Inc&rft.eissn=2168-8184&rft.volume=14&rft.issue=3&rft_id=info:doi/10.7759%2Fcureus.22804&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-8184&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-8184&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-8184&client=summon